Emergence, Mechanism, and Clinical Implications of Reduced Glycopeptide Susceptibility in Staphylococcus aureus
| Autor: | Geisel R, Franz-Josef Schmitz, A. C. Fluit, Labischinski H |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Microbiology (medical)
Staphylococcus aureus medicine.medical_specialty Micrococcaceae medicine.drug_class Antibiotics Microbial Sensitivity Tests medicine.disease_cause Risk Assessment Sensitivity and Specificity Microbiology Medical microbiology Vancomycin medicine Humans Antibacterial agent Dose-Response Relationship Drug biology business.industry Vancomycin Resistance General Medicine Staphylococcal Infections biology.organism_classification Glycopeptide Anti-Bacterial Agents Infectious Diseases Immunology business Bacteria medicine.drug |
| Zdroj: | European Journal of Clinical Microbiology and Infectious Diseases. 20:685-697 |
| ISSN: | 1435-4373 0934-9723 |
| DOI: | 10.1007/s100960100595 |
| Popis: | In order to understand the mechanism(s) of the resistance/reduced susceptibility of Staphylococcus aureus to glycopeptide antibiotics, the current data on the modes of action of glycopeptides were reviewed. In addition, the different test systems for detecting vancomycin resistance and the clinical relevance of resistant Staphylococcus aureus were analyzed. Finally, strategies to prevent the nosocomial spread of these bacteria are presented, as are new therapeutic options. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink